Skip to main content
NCBI home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2004 Oct;80(5):335–341. doi: 10.1136/sti.2004.012856

Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening

D LaMontagne 1, K Fenton 1, S Randall 1, S Anderson 1, P Carter 1, b on 1
PMCID: PMC1744892  PMID: 15459399

Abstract

Methods: Cross sectional study of the first year's screening data from the NCSP. A standardised core dataset for each screening test was collected from 302 screening venues, excluding genitourinary medicine (GUM) clinics, across 10 phase 1 programme areas. We estimated chlamydia positivity by demographic and behavioural characteristics, and investigated factors associated with infection through univariate and multivariate analyses.

Results: Chlamydia positivity among people under 25 years of age screened in non-GUM settings was 10.1% (1538/15 241) in women and 13.3% (156/1172) in men. Risk factors varied by sex: for women—age 16–19, non-white ethnicity, and sexual behaviours were associated with infection; for men—only age 20–24 and non-white ethnicity were associated with infection.

Discussion: In the first phase of the NCSP, 16 413 opportunistic screens among young adults under 25 years of age were performed at non-GUM settings and testing volume increased over time. Rates of disease were similar to those found during the English screening pilot and were comparable to the first year of widespread screening in Sweden and the United States. The screening programme in England will continue to expand as further phases are included, with national coverage anticipated by 2008.

Full Text

The Full Text of this article is available as a PDF (97.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addiss D. G., Vaughn M. L., Hillis S. D., Ludka D., Amsterdam L., Davis J. P. History and features of the Wisconsin Chlamydia trachomatis control program. Fam Plann Perspect. 1994 Mar-Apr;26(2):83-6, 89. [PubMed] [Google Scholar]
  2. Addiss D. G., Vaughn M. L., Ludka D., Pfister J., Davis J. P. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis. 1993 Jan-Feb;20(1):28–35. doi: 10.1097/00007435-199301000-00006. [DOI] [PubMed] [Google Scholar]
  3. Britton T. F., Delisle S., Fine D. STDs and family planning clinics: a regional program for Chlamydia control that works. Am J Gynecol Health. 1992 May-Jun;6(3):80–87. [PubMed] [Google Scholar]
  4. Dicker L. W., Mosure D. J., Levine W. C. Chlamydia positivity versus prevalence. What's the difference? Sex Transm Dis. 1998 May;25(5):251–253. doi: 10.1097/00007435-199805000-00006. [DOI] [PubMed] [Google Scholar]
  5. Fenton K. A., Korovessis C., Johnson A. M., McCadden A., McManus S., Wellings K., Mercer C. H., Carder C., Copas A. J., Nanchahal K. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet. 2001 Dec 1;358(9296):1851–1854. doi: 10.1016/S0140-6736(01)06886-6. [DOI] [PubMed] [Google Scholar]
  6. Handsfield H. H., Jasman L. L., Roberts P. L., Hanson V. W., Kothenbeutel R. L., Stamm W. E. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA. 1986 Apr 4;255(13):1730–1734. [PubMed] [Google Scholar]
  7. Herrmann B., Egger M. Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1985-1993: declining rates for how much longer? Sex Transm Dis. 1995 Jul-Aug;22(4):253–260. doi: 10.1097/00007435-199507000-00009. [DOI] [PubMed] [Google Scholar]
  8. Honey E., Augood C., Templeton A., Russell I., Paavonen J., Mårdh P-A, Stary A., Stray-Pedersen B. Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies. Sex Transm Infect. 2002 Dec;78(6):406–412. doi: 10.1136/sti.78.6.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Idahl A., Boman J., Kumlin U., Olofsson J. I. Demonstration of Chlamydia trachomatis IgG antibodies in the male partner of the infertile couple is correlated with a reduced likelihood of achieving pregnancy. Hum Reprod. 2004 May;19(5):1121–1126. doi: 10.1093/humrep/deh155. [DOI] [PubMed] [Google Scholar]
  10. Kretzschmar M., Welte R., van den Hoek A., Postma M. J. Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. Am J Epidemiol. 2001 Jan 1;153(1):90–101. doi: 10.1093/aje/153.1.90. [DOI] [PubMed] [Google Scholar]
  11. Kretzschmar M., van Duynhoven Y. T., Severijnen A. J. Modeling prevention strategies for gonorrhea and Chlamydia using stochastic network simulations. Am J Epidemiol. 1996 Aug 1;144(3):306–317. doi: 10.1093/oxfordjournals.aje.a008926. [DOI] [PubMed] [Google Scholar]
  12. Levine William C., Dicker Linda W., Devine Owen, Mosure Debra J. Indirect estimation of Chlamydia screening coverage using public health surveillance data. Am J Epidemiol. 2004 Jul 1;160(1):91–96. doi: 10.1093/aje/kwh162. [DOI] [PubMed] [Google Scholar]
  13. Marrazzo J. M., Celum C. L., Hillis S. D., Fine D., DeLisle S., Handsfield H. H. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy. Sex Transm Dis. 1997 Mar;24(3):131–141. doi: 10.1097/00007435-199703000-00003. [DOI] [PubMed] [Google Scholar]
  14. McNulty Cliodna A. M., Freeman Elaine, Bowen Jo, Shefras Julia, Fenton Kevin A. Barriers to opportunistic chlamydia testing in primary care. Br J Gen Pract. 2004 Jul;54(504):508–514. [PMC free article] [PubMed] [Google Scholar]
  15. Mertz K. J., Levine W. C., Mosure D. J., Berman S. M., Dorian K. J. Trends in the prevalence of chlamydial infections. The impact of community-wide testing. Sex Transm Dis. 1997 Mar;24(3):169–175. doi: 10.1097/00007435-199703000-00009. [DOI] [PubMed] [Google Scholar]
  16. Oakeshott Pippa, Hay Phillip, Pakianathan Mark. Chlamydia screening in primary care. Br J Gen Pract. 2004 Jul;54(504):491–493. [PMC free article] [PubMed] [Google Scholar]
  17. Ostergaard L., Andersen B., Møller J. K., Olesen F. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. Clin Infect Dis. 2000 Oct 25;31(4):951–957. doi: 10.1086/318139. [DOI] [PubMed] [Google Scholar]
  18. Paavonen J., Puolakkainen M., Paukku M., Sintonen H. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program. Obstet Gynecol. 1998 Aug;92(2):292–298. doi: 10.1016/s0029-7844(98)00167-7. [DOI] [PubMed] [Google Scholar]
  19. Pimenta J. M., Catchpole M., Rogers P. A., Hopwood J., Randall S., Mallinson H., Perkins E., Jackson N., Carlisle C., Hewitt G. Opportunistic screening for genital chlamydial infection. II: prevalence among healthcare attenders, outcome, and evaluation of positive cases. Sex Transm Infect. 2003 Feb;79(1):22–27. doi: 10.1136/sti.79.1.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pimenta J. M., Catchpole M., Rogers P. A., Perkins E., Jackson N., Carlisle C., Randall S., Hopwood J., Hewitt G., Underhill G. Opportunistic screening for genital chlamydial infection. I: acceptability of urine testing in primary and secondary healthcare settings. Sex Transm Infect. 2003 Feb;79(1):16–21. doi: 10.1136/sti.79.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Scholes D., Stergachis A., Heidrich F. E., Andrilla H., Holmes K. K., Stamm W. E. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996 May 23;334(21):1362–1366. doi: 10.1056/NEJM199605233342103. [DOI] [PubMed] [Google Scholar]
  22. Welte R., Kretzschmar M., Leidl R., van den Hoek A., Jager J. C., Postma M. J. Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. Sex Transm Dis. 2000 Oct;27(9):518–529. doi: 10.1097/00007435-200010000-00005. [DOI] [PubMed] [Google Scholar]
  23. Wilson J. S., Honey E., Templeton A., Paavonen J., Mårdh P. A., Stray-Pedersen B., EU Biomed Concerted Action Group A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update. 2002 Jul-Aug;8(4):385–394. doi: 10.1093/humupd/8.4.385. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[National Chlamydia Screening Steering Group]
straninf_80_5_335__index.html (1.4KB, html)

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES